Cinchophen

Cinchophen

SCHEMBL4805149

O=C(O)c1cc(-c2ccccc2)nc2ccccc12.[Eu]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.97
PDE10A Q9Y233 2/20 0.97
LMNA P02545 1/20 0.97
SMN1; SMN2 Q16637 1/20 0.97
DHODH Q02127 6/20 0.90
POLB P06746 1/20 0.79
AKR1C3 P42330 1/20 0.75
AKR1C2 P52895 1/20 0.75
AKR1C1 Q04828 1/20 0.75
HSD17B10 Q99714 2/20 0.68
ALDH1A1 P00352 1/20 0.68
TP53 P04637 1/20 0.68
CYP1A2 P05177 1/20 0.68
CYP2C19 P33261 1/20 0.68
HIF1A Q16665 1/20 0.68
KMT2A Q03164 2/20 0.68
MEN1 O00255 1/20 0.68
GFER P55789 1/20 0.68
NPC1 O15118 1/20 0.67
RAB9A P51151 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinchophen SCHEMBL25519 0.98 KDM4E (1.00) KDM4EPDE10ALMNASMN1; SMN2DHODH
Cinchophen SCHEMBL29376617 0.98 KDM4E (1.00) KDM4EPDE10ALMNASMN1; SMN2DHODH
Cinchophen SCHEMBL7588217 0.98 KDM4E (1.00) KDM4EPDE10ALMNASMN1; SMN2DHODH
Cinchophen SCHEMBL10757475 0.97 KDM4E (0.97) KDM4EPDE10ALMNASMN1; SMN2DHODH
Cinchophen SCHEMBL4464779 0.97 KDM4E (0.97) KDM4EPDE10ALMNASMN1; SMN2DHODH
SCHEMBL29536364 0.95 DHODH (1.00) KDM4EPDE10ALMNASMN1; SMN2DHODH
Cinchophen SCHEMBL27543969 0.95 KDM4E (0.93) KDM4EPDE10ALMNASMN1; SMN2DHODH
SCHEMBL2467110 0.95 DHODH (1.00) KDM4EPDE10ALMNASMN1; SMN2DHODH
SCHEMBL29359819 0.89 KDM4E (0.83) KDM4EPDE10ALMNASMN1; SMN2DHODH
SCHEMBL18746 0.89 KDM4E (0.83) KDM4EPDE10ALMNASMN1; SMN2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7399434-B2 Rare metal compounds and mixtures of these HONEYWELL INTERNATIONAL INC (US) 2008-07-15 US disclosed
CN-1329399-C Rare earth metal compounds and mixtures of these HONEYWELL SPECIALTY CHEMICALS (DE) 2007-08-01 CN disclosed
US-7198732-B2 Rare earth metal compounds and mixtures of these HONEYWELL INTERNATIONAL INC. (US) 2007-04-03 US disclosed
US-20070051929-A1 Rare metal compounds and mixtures of these HONEYWELL INTERNATIONAL INC. (US) 2007-03-08 US disclosed
CN-1608072-A Rare earth metal compounds and mixtures thereof HONEYWELL SPECIALTY CHEMICALS (DE) 2005-04-20 CN disclosed
EP-1456213-B1 RARE EARTH METAL COMPOUNDS AND MIXTURES OF THESE HONEYWELL SPECIALTY CHEMICALS (DE) 2005-03-30 EP disclosed
US-20040262575-A1 Rare earth metal compounds and mixtures of these POTRAWA THOMAS 2004-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040262575-A1 Rare earth metal compounds and mixtures of these SOD1, ERCC4, ERCC1 KDM4E 4140/4885PDE10A 3524/4885LMNA 1508/4885
US-20070051929-A1 Rare metal compounds and mixtures of these RUVBL2, SOD1, MSH6 KDM4E 3196/4885PDE10A 3160/4885LMNA 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.